tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CEO’s Multi-Million Dollar Stock Sale Shakes Up Hims & Hers Health

CEO’s Multi-Million Dollar Stock Sale Shakes Up Hims & Hers Health

New insider activity at Hims & Hers Health ( (HIMS) ) has taken place on August 11, 2025.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

CEO Andrew Dudum has recently sold 660,000 shares of Hims & Hers Health stock, amounting to a significant transaction worth $33,382,800.

Recent Updates on HIMS stock

In the last 24 hours, Hims & Hers Health (HIMS) experienced mixed market reactions following its Q2 2025 earnings report. The company reported robust revenue growth of 73% year-over-year, reaching $545 million, and a significant increase in net income by 220% to $43 million, driven by a growing subscriber base and personalized treatment plans. Despite these positive metrics, the stock faced challenges such as a decline in GLP-1 revenue and negative free cash flow due to increased investments in working capital and supply chain. Deutsche Bank raised its price target for Hims & Hers, citing strong growth and strategic expansions into new markets and healthcare offerings. However, Bank of America expressed a more cautious outlook, highlighting financial challenges and a potential downside. The mixed sentiment was reflected in the options market, with a put/call ratio indicating a modestly bullish tone. Overall, while the company is optimistic about its future growth prospects, it faces short-term financial hurdles.

Spark’s Take on HIMS Stock

According to Spark, TipRanks’ AI Analyst, HIMS is a Outperform.

Hims & Hers Health’s strong financial performance and positive earnings call sentiment are the primary drivers of its stock score. The company’s robust revenue growth, strategic partnerships, and expansion efforts support its growth trajectory. However, the high P/E ratio suggests that the stock may be overvalued, posing a risk if growth expectations are not met. Technical indicators support a bullish trend, adding to the positive outlook.

To see Spark’s full report on HIMS stock, click here.

More about Hims & Hers Health

YTD Price Performance: 106.11%

Average Trading Volume: 42,507,032

Technical Sentiment Signal: Buy

Current Market Cap: $11.74B

Disclaimer & DisclosureReport an Issue

1